AZD6234
SELENE-Asia
AstraZeneca · Phase 3 · Not yet recruiting · Enrollment 330
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| AZD6234 Higher Target-Dose | Obesity + T2D | n/r | n/r | n/r | n/r |
| AZD6234 Lower Target-Dose | Obesity + T2D | n/r | n/r | n/r | n/r |
| Placebo | Obesity + T2D | n/r | n/r | n/r | n/r |